Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alan S. Gamis, MD, MPH
Children's Mercy Hospital Kansas City
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
237 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Children'S Hospital
Randwick, New South Wales, Australia
- Children'S Hospital at Westmead
Westmead, New South Wales, Australia
- Royal Children'S Hospital
Brisbane, Queensland, Australia
- Women'S and Children'S Hospital
North Adelaide, South Australia, Australia
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Janeway Children'S Health and Rehabilitation Centre
St. John's, Newfoundland and Labrador, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Children'S Hospital of Western Ontario
London, Ontario, Canada
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Mcgill University Health Center - Montreal Children'S Hospital
Montreal, Quebec, Canada
- Centre de Recherche Du Centre Hospitalier de L'Universite Laval
Sainte-Foy, Quebec, Canada
- Allan Blair Cancer Centre at Pasqua Hospital
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Academisch Ziekenhuis Groningen
Groningen, Netherlands
- Starship Children'S Hospital
Auckland, New Zealand
- Puerto Rico Cancer Center at University of Puerto Rico - Medical Sciences Campus
San Juan, Puerto Rico
- San Jorge Childrens Hospital
Santurce, Puerto Rico
- Swiss Pediatric Oncology Group Bern
Bern, Switzerland
- Swiss Pediatric Oncology Group Geneva
Geneva, Switzerland
- Swiss Pediatric Oncology Group Lausanne
Lausanne, Switzerland
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- University of South Alabama Cancer Research Institute
Mobile, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Rebecca and John Moores Ucsd Cancer Center
La Jolla, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Jonathan Jaques Children'S Cancer Center at Miller Children'S Hospital
Long Beach, California, United States
- Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
Los Angeles, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 1999
- Primary completion
- 31 Mar 2007
- Completion
- 30 Apr 2012
- Last update posted
- 27 Jun 2013
- Registered enrollment
- 254
- Registry id
- NCT00003593
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.